These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 29377193

  • 21. Clinical Evaluation and Prognosis.
    Hernández-Gea V, Berzigotti A.
    Dig Dis; 2015; 33(4):515-23. PubMed ID: 26159268
    [Abstract] [Full Text] [Related]

  • 22. Prognostic markers in patients who have recovered from an acute variceal bleeding: role of HVPG measurement.
    Bañares R, Catalina MV, Ripoll C, Rincón D.
    Dis Markers; 2011; 31(3):165-9. PubMed ID: 22045402
    [No Abstract] [Full Text] [Related]

  • 23. Von Willebrand factor processing in patients with advanced chronic liver disease and its relation to portal hypertension and clinical outcome.
    Simbrunner B, Villesen IF, Scheiner B, Paternostro R, Schwabl P, Stättermayer AF, Marculescu R, Pinter M, Quehenberger P, Trauner M, Karsdal M, Lisman T, Reiberger T, Leeming DJ, Mandorfer M.
    Hepatol Int; 2023 Dec; 17(6):1532-1544. PubMed ID: 37605068
    [Abstract] [Full Text] [Related]

  • 24. Effects of the adjunctive probiotic VSL#3 on portal haemodynamics in patients with cirrhosis and large varices: a randomized trial.
    Gupta N, Kumar A, Sharma P, Garg V, Sharma BC, Sarin SK.
    Liver Int; 2013 Sep; 33(8):1148-57. PubMed ID: 23601333
    [Abstract] [Full Text] [Related]

  • 25. Von Willebrand factor for outcome prediction within different clinical stages of advanced chronic liver disease.
    Dominik N, Scheiner B, Zanetto A, Balcar L, Semmler G, Campello E, Schwarz M, Paternostro R, Simbrunner B, Hofer BS, Stättermayer AF, Pinter M, Trauner M, Quehenberger P, Simioni P, Reiberger T, Mandorfer M.
    Aliment Pharmacol Ther; 2024 Jun; 59(11):1376-1386. PubMed ID: 38482706
    [Abstract] [Full Text] [Related]

  • 26. [Evaluation and treatment of portal hypertension].
    Brůha R, Petrtýl J.
    Cas Lek Cesk; 2016 Jun; 155(2):22-6. PubMed ID: 27088788
    [Abstract] [Full Text] [Related]

  • 27. New concepts on the clinical course and stratification of compensated and decompensated cirrhosis.
    D'Amico G, Morabito A, D'Amico M, Pasta L, Malizia G, Rebora P, Valsecchi MG.
    Hepatol Int; 2018 Feb; 12(Suppl 1):34-43. PubMed ID: 28681347
    [Abstract] [Full Text] [Related]

  • 28. [Measurement of hepatic venous pressure gradient in liver cirrhosis: relationship with the status of cirrhosis, varices, and ascites in Korea].
    Kim MY, Baik SK, Suk KT, Yea CJ, Lee IY, Kim JW, Cha SH, Kim YJ, Um SH, Han KH.
    Korean J Hepatol; 2008 Jun; 14(2):150-8. PubMed ID: 18617762
    [Abstract] [Full Text] [Related]

  • 29. Von Willebrand factor antigen for detection of hepatopulmonary syndrome in patients with cirrhosis.
    Horvatits T, Drolz A, Roedl K, Herkner H, Ferlitsch A, Perkmann T, Müller C, Trauner M, Schenk P, Fuhrmann V.
    J Hepatol; 2014 Sep; 61(3):544-9. PubMed ID: 24798623
    [Abstract] [Full Text] [Related]

  • 30. Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis.
    Ripoll C, Groszmann RJ, Garcia-Tsao G, Bosch J, Grace N, Burroughs A, Planas R, Escorsell A, Garcia-Pagan JC, Makuch R, Patch D, Matloff DS, Portal Hypertension Collaborative Group.
    J Hepatol; 2009 May; 50(5):923-8. PubMed ID: 19303163
    [Abstract] [Full Text] [Related]

  • 31. Plasma Nogo-A and placental growth factor levels are associated with portal hypertension in patients with liver cirrhosis.
    Gelman S, Salteniene V, Pranculis A, Skieceviciene J, Zykus R, Petrauskas D, Kupcinskas L, Canbay A, Link A, Kupcinskas J.
    World J Gastroenterol; 2019 Jun 21; 25(23):2935-2946. PubMed ID: 31249451
    [Abstract] [Full Text] [Related]

  • 32. Comparison of hepatic venous pressure gradient and endoscopic grading of esophageal varices.
    Lee E, Kim YJ, Goo DE, Yang SB, Kim HJ, Jang JY, Jeong SW.
    World J Gastroenterol; 2016 Mar 21; 22(11):3212-9. PubMed ID: 27003998
    [Abstract] [Full Text] [Related]

  • 33. Transfusion with Cryoprecipitate for Very Low Fibrinogen Levels Does Not Affect Bleeding or Survival in Critically Ill Cirrhosis Patients.
    Budnick IM, Davis JPE, Sundararaghavan A, Konkol SB, Lau CE, Alsobrooks JP, Stotts MJ, Intagliata NM, Lisman T, Northup PG.
    Thromb Haemost; 2021 Oct 21; 121(10):1317-1325. PubMed ID: 33450778
    [Abstract] [Full Text] [Related]

  • 34. Prognostic indicators of survival in patients with compensated and decompensated cirrhosis.
    Zipprich A, Garcia-Tsao G, Rogowski S, Fleig WE, Seufferlein T, Dollinger MM.
    Liver Int; 2012 Oct 21; 32(9):1407-14. PubMed ID: 22679906
    [Abstract] [Full Text] [Related]

  • 35. Non-invasive model predicting clinically-significant portal hypertension in patients with advanced fibrosis.
    Park SH, Park TE, Kim YM, Kim SJ, Baik GH, Kim JB, Kim DJ.
    J Gastroenterol Hepatol; 2009 Jul 21; 24(7):1289-93. PubMed ID: 19682196
    [Abstract] [Full Text] [Related]

  • 36. Von-Willebrand factor as a predictor of three-month mortality in patients with liver cirrhosis compared to MELD score.
    Curakova Ristovska E, Genadieva-Dimitrova M, Caloska-Ivanova V, Misevski J.
    Acta Gastroenterol Belg; 2019 Jul 21; 82(4):487-493. PubMed ID: 31950803
    [Abstract] [Full Text] [Related]

  • 37. Prognostic value of hepatic venous pressure gradient in patients with compensated chronic hepatitis C-related cirrhosis.
    Rincón D, Lo Iacono O, Tejedor M, Hernando A, Ripoll C, Catalina MV, Salcedo M, Matilla A, Senosiain M, Clemente G, Molinero LM, Albillos A, Bañares R.
    Scand J Gastroenterol; 2013 Apr 21; 48(4):487-95. PubMed ID: 22871085
    [Abstract] [Full Text] [Related]

  • 38. Altered von Willebrand Factor and ADAMTS13 Levels in Children With Cirrhosis and Extrahepatic Portal Hypertension.
    Islek A, Ilhan D, Ozturk N, Guven B, Sag E.
    J Pediatr Hematol Oncol; 2021 Oct 01; 43(7):e951-e956. PubMed ID: 33369998
    [Abstract] [Full Text] [Related]

  • 39. Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis.
    Colecchia A, Montrone L, Scaioli E, Bacchi-Reggiani ML, Colli A, Casazza G, Schiumerini R, Turco L, Di Biase AR, Mazzella G, Marzi L, Arena U, Pinzani M, Festi D.
    Gastroenterology; 2012 Sep 01; 143(3):646-654. PubMed ID: 22643348
    [Abstract] [Full Text] [Related]

  • 40. The predictive value of serum laminin for the risk of variceal bleeding related to portal pressure levels.
    Kondo M, Miszputen SJ, Leite-mor MM, Parise ER.
    Hepatogastroenterology; 1995 Sep 01; 42(5):542-5. PubMed ID: 8751212
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.